Keywords: Elan, Debt retirement, EDT unit, Alzhemer's, ELND005, Phase III

Elan plans to retire $500 million of debt; says time not right to sell EDT; updates on Alzheimer’s drug

Article | 10 August 2010

Print This

Irish drugmaker Elan Corp announced this morning that it will retire up to $500 million in outstanding debt due to mature ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in